Laboratory Testing for Diagnosing Calciphylaxis
C-reactive protein is the MOST helpful laboratory test in diagnosing calciphylaxis, as standard laboratory tests like calcium and phosphate levels are not predictive of outcomes and cannot be used for guiding therapy in this condition. 1
Understanding Calciphylaxis
Calciphylaxis is a rare and life-threatening complication of chronic kidney disease-mineral and bone disorder (CKD-MBD) characterized by:
- Vascular calcification leading to ischemic skin ulceration 1
- High mortality rates (50-80% at two years) primarily due to sepsis 2
- Medial calcification of small-sized vessels 3
Diagnostic Approach
Laboratory Testing Limitations
- Serum calcium and phosphate levels are not predictive of outcomes in calciphylaxis 1
- These standard mineral metabolism markers cannot be reliably used for guiding therapy 1
- C-reactive protein is most helpful as it reflects the inflammatory component of calciphylaxis 1
Histopathological Diagnosis Challenges
- Skin biopsy, while traditionally used, has significant limitations:
Imaging Studies
- Radiological findings of superficial vascular calcifications can be sensitive for diagnosis 5
- Imaging modalities that may detect calcifications include:
- Computed tomography
- Ultrasound
- Plain radiography
- Mammography (for breast involvement) 5
Risk Factors and Associated Conditions
Advanced Diagnostic Considerations
- Bone biopsy may be necessary to differentiate between high and low bone turnover states, which require different treatment approaches 6
- Special staining techniques for calcium detection:
- Von Kossa stain
- Alizarin red stain (may show larger deposits with birefringence) 4
- Perieccrine calcium deposition is highly specific to calciphylaxis and may be present even when vascular calcification is not identified 4
Treatment Implications
- Treatment should be directed based on the underlying bone disorder, which cannot be reliably determined by laboratory tests alone 6
- C-reactive protein levels can help monitor inflammatory response to treatment 1
- SNF472 (hexaphosphate phytate) has shown promise in clinical trials for calciphylaxis, with improvements in wound healing and reduced hospitalizations 1